1-Propanesulfonamide, N-[3-[(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl]-
![BK81JE | 918504-27-5 | 1-Propanesulfonamide, N-[3-[(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl]-](https://qncdn.chemcd.cn/alchemypharm/AP10743.png "BK81JE | 918504-27-5 | 1-Propanesulfonamide, N-[3-[(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl]-")
Catalog No.: BK81JE
CAS.RN：918504-27-5
Molecular Formula: C17H14BrF2N3O3S
Molecular Weight: 458.28 g/mol
Purity: NLT 98%
Intermediates of Vemurafenib
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA299N | Vemurafenib API | 918504-65-1 |
| BK6S9Q | 2,6-difluoro-3-(propylsulfonamido)benzoic acid | 1103234-56-5 |
| BK81JE | 1-Propanesulfonamide, N-[3-[(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl]- | 918504-27-5 |
| BK6RZ8 | Benzoic acid, 3-amino-2,6-difluoro-, methyl ester | 84832-02-0 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
